MX2022011539A - Metodo de produccion de una composicion de suero para la prevencion o el tratamiento de enfermedades infecciosas relacionadas con las mucosas en mamiferos jovenes, composicion de suero producida de este modo y uso de la misma. - Google Patents
Metodo de produccion de una composicion de suero para la prevencion o el tratamiento de enfermedades infecciosas relacionadas con las mucosas en mamiferos jovenes, composicion de suero producida de este modo y uso de la misma.Info
- Publication number
- MX2022011539A MX2022011539A MX2022011539A MX2022011539A MX2022011539A MX 2022011539 A MX2022011539 A MX 2022011539A MX 2022011539 A MX2022011539 A MX 2022011539A MX 2022011539 A MX2022011539 A MX 2022011539A MX 2022011539 A MX2022011539 A MX 2022011539A
- Authority
- MX
- Mexico
- Prior art keywords
- mucosa
- serum composition
- preventing
- serum
- producing
- Prior art date
Links
- 210000004877 mucosa Anatomy 0.000 title abstract 5
- 210000002966 serum Anatomy 0.000 title abstract 5
- 208000015181 infectious disease Diseases 0.000 title abstract 4
- 208000035473 Communicable disease Diseases 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 4
- 244000309466 calf Species 0.000 abstract 3
- 244000052769 pathogen Species 0.000 abstract 3
- 241000283690 Bos taurus Species 0.000 abstract 2
- 230000002458 infectious effect Effects 0.000 abstract 2
- 241000282887 Suidae Species 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 239000012678 infectious agent Substances 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39516—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from serum, plasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/70—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in livestock or poultry
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Developmental Biology & Embryology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención proporciona un método de producción de un suero que contiene anticuerpos protectores con inmunidad de las mucosas, un suero PAMI, contra los patógenos infecciosos relacionados con las mucosas de un cerdo o un bovino adulto, que comprende una etapa de administración de los patógenos infecciosos relacionados con las mucosas al cerdo o al bovino adulto a través de una vía mucosa tal como la administración oral o nasal; y un método de prevención y/o de tratamiento de enfermedades infecciosas de las mucosas en lechones y terneros mediante la administración oral o intravenosa del suero PAMI producido mediante el método anterior a lechones o terneros. En los experimentos realizados por el método de la presente invención, se previno y/o se trató con éxito la infección de lechones y terneros jóvenes con patógenos infecciosos relacionados con las mucosas.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020200035466A KR102151962B1 (ko) | 2020-03-24 | 2020-03-24 | 어린 포유동물의 전염성 질병을 예방 또는 치료하기 위한 혈청 조성물의 제조방법, 상기 방법에 의해 제조된 혈청 조성물 및 이의 용도 |
| KR1020200109320A KR102234525B1 (ko) | 2020-08-28 | 2020-08-28 | 송아지의 점막관련 전염성 질병을 예방 또는 치료하기 위한 혈청의 제조방법, 상기 방법에 의해 제조된 혈청 및 이의 용도 |
| PCT/KR2020/015986 WO2021194038A1 (ko) | 2020-03-24 | 2020-11-13 | 어린 포유동물의 점막관련 전염성 질병을 예방 또는 치료하기 위한 혈청 조성물의 제조방법, 상기 방법에 의해 제조된 혈청 조성물 및 이의 용도 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022011539A true MX2022011539A (es) | 2022-10-13 |
Family
ID=77892720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022011539A MX2022011539A (es) | 2020-03-24 | 2020-11-13 | Metodo de produccion de una composicion de suero para la prevencion o el tratamiento de enfermedades infecciosas relacionadas con las mucosas en mamiferos jovenes, composicion de suero producida de este modo y uso de la misma. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230125824A1 (es) |
| EP (1) | EP4129309A4 (es) |
| JP (1) | JP7672162B2 (es) |
| CN (1) | CN114901293B (es) |
| AU (2) | AU2020437632A1 (es) |
| BR (1) | BR112022018160A2 (es) |
| CA (1) | CA3175456A1 (es) |
| CL (1) | CL2022002419A1 (es) |
| MX (1) | MX2022011539A (es) |
| PH (1) | PH12022552335A1 (es) |
| WO (1) | WO2021194038A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113845588B (zh) * | 2021-05-26 | 2023-06-09 | 西南民族大学 | 一种抗猪轮状病毒的卵黄抗体的制备方法及其用途 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0000891D0 (en) * | 2000-01-14 | 2000-03-08 | Allergy Therapeutics Ltd | Formulation |
| US20090017069A1 (en) * | 2000-06-29 | 2009-01-15 | Lipid Sciences, Inc. | SARS Vaccine Compositions and Methods of Making and Using Them |
| BR0206293B1 (pt) * | 2001-01-03 | 2015-01-20 | Epitopix Llc | composições compreendendo polipeptídeos receptores de sideróforos e porinas de micróbio gram-negativo, bem como métodos de isolar polipeptídeos de membrana externa |
| CN1796416A (zh) * | 2004-12-29 | 2006-07-05 | 中山大学 | 抗禽流感病毒免疫球蛋白、制备方法和其制剂 |
| US7572620B2 (en) * | 2005-01-11 | 2009-08-11 | Wisconsin Alumni Research Foundation | H3 equine influenza A virus |
| US20070264264A1 (en) * | 2005-08-30 | 2007-11-15 | La Belle Associates, Inc. | Method and composition for conferring immunity in mammals |
| JP4828189B2 (ja) * | 2005-09-14 | 2011-11-30 | 雅美 森山 | 分泌型ＩｇＡ及びＩｇＧ抗体誘導剤 |
| CN103865892B (zh) * | 2005-10-18 | 2017-04-12 | 诺瓦瓦克斯股份有限公司 | 功能性流感病毒样颗粒(vlp) |
| RU2396979C2 (ru) | 2008-07-29 | 2010-08-20 | Виталий Александрович Сергеев | Гипериммунная поливалентная сыворотка против массовых вирусных болезней крупного рогатого скота |
| WO2010111586A2 (en) * | 2009-03-27 | 2010-09-30 | Arizona Board Of Regents Acting For And On Behalf Of Arizona State University | Mucosal immunization |
| JP2011057605A (ja) * | 2009-09-09 | 2011-03-24 | Masami Moriyama | 粘膜投与型ワクチン |
| CN102933230B (zh) * | 2010-04-15 | 2016-03-02 | 株式会社新日本科学 | 用于鼻内递送的方法和组合物 |
| RU2438709C1 (ru) | 2010-12-02 | 2012-01-10 | Общество с ограниченной ответственностью "Ветактив" | Сыворотка против болезней крупного рогатого скота, вызываемых вирусами инфекционного ринотрахеита, парагриппа, рота, корона и диареи - болезни слизистых, полиспецифическая гипериммунная, способ профилактики и лечения болезней крупного рогатого скота, вызываемых вирусами инфекционного ринотрахеита, парагриппа, рота, корона и диареи - болезни слизистых |
| JP5650780B2 (ja) * | 2012-04-04 | 2015-01-07 | 日東電工株式会社 | ワクチン組成物 |
| EP3001837A4 (en) * | 2013-03-15 | 2017-05-17 | Huiru Wang | Biological therapeutics for infection-relating disorders or conditions |
| RU2587323C1 (ru) * | 2015-01-26 | 2016-06-20 | Федеральное государственное бюджетное научное учреждение "Прикаспийский зональный научно-исследовательский ветеринарный институт" (ФГБНУ "Прикаспийский зональный НИВИ" ФАНО России") | Способ получения гипериммунной сыворотки против парагриппа-3 крупного рогатого скота |
| WO2019035972A1 (en) * | 2017-08-16 | 2019-02-21 | Georgia State University Research Foundation, Inc. | SEQUENTIAL IMMUNIZATIONS WITH HIV-1 ENV VIRUS TYPE PARTICLES |
-
2020
- 2020-11-13 JP JP2022541643A patent/JP7672162B2/ja active Active
- 2020-11-13 EP EP20927889.4A patent/EP4129309A4/en active Pending
- 2020-11-13 MX MX2022011539A patent/MX2022011539A/es unknown
- 2020-11-13 BR BR112022018160A patent/BR112022018160A2/pt unknown
- 2020-11-13 CA CA3175456A patent/CA3175456A1/en active Pending
- 2020-11-13 CN CN202080091266.5A patent/CN114901293B/zh active Active
- 2020-11-13 PH PH1/2022/552335A patent/PH12022552335A1/en unknown
- 2020-11-13 US US17/801,572 patent/US20230125824A1/en active Pending
- 2020-11-13 WO PCT/KR2020/015986 patent/WO2021194038A1/ko not_active Ceased
- 2020-11-13 AU AU2020437632A patent/AU2020437632A1/en not_active Abandoned
-
2022
- 2022-09-05 CL CL2022002419A patent/CL2022002419A1/es unknown
-
2025
- 2025-02-17 AU AU2025201124A patent/AU2025201124A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3175456A1 (en) | 2021-09-30 |
| AU2025201124A1 (en) | 2025-03-06 |
| WO2021194038A1 (ko) | 2021-09-30 |
| CN114901293A (zh) | 2022-08-12 |
| JP7672162B2 (ja) | 2025-05-07 |
| US20230125824A1 (en) | 2023-04-27 |
| CL2022002419A1 (es) | 2023-04-14 |
| EP4129309A1 (en) | 2023-02-08 |
| CN114901293B (zh) | 2024-09-24 |
| BR112022018160A2 (pt) | 2022-10-25 |
| AU2020437632A1 (en) | 2022-10-13 |
| EP4129309A4 (en) | 2023-11-01 |
| PH12022552335A1 (en) | 2023-12-18 |
| JP2023518924A (ja) | 2023-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR034678A1 (es) | Procedimiento de tratamiento o prevencion de una enfermedad o trastorno en un animal causada por mycoplasma hyopneumoniae | |
| CO5611162A2 (es) | Metodos para prevenir enfermedades reproductivas en el ganado vacuno | |
| AR093185A1 (es) | Virus prrs (sindrome reproductivo y respiratorio porcino) que induce al interferon tipo i en celulas susceptibles | |
| Shope | Experiments on the epidemiology of Pseudorabies: I. Mode of transmission of the disease in swine and their possible role in its spread to cattle | |
| AR045312A1 (es) | Metodo que comprende la administracion nasal de xilitol a un mamifero no humano | |
| CO2023003242A2 (es) | Vacuna contra el coronavirus y procedimiento para la preparación de la misma | |
| MX2022011539A (es) | Metodo de produccion de una composicion de suero para la prevencion o el tratamiento de enfermedades infecciosas relacionadas con las mucosas en mamiferos jovenes, composicion de suero producida de este modo y uso de la misma. | |
| Verma et al. | Intra-dermal administration of rabies vaccines in developing countries: at an affordable cost | |
| CL2022002832A1 (es) | Vacuna inactivada para sars-cov-2 y preparación de la misma | |
| RU2012105524A (ru) | Надъязычные вакцины и аппликаторы | |
| MX2023005182A (es) | Parvovirus canino. | |
| CN107279535B (zh) | 一种用于新生仔猪驱虫的饲料添加剂及生产方法 | |
| AR048671A1 (es) | Procedimiento de vacunacion contra la infeccion testicular por bvdv | |
| Guerrero et al. | The activity of closantel as an equine antiparasitic agent | |
| PE20240051A1 (es) | Metodos para el tratamiento del cancer con administracion subcutanea de anticuerpos anti-pd1 | |
| Abbas et al. | Parenteral Combined with Topical Treatment of Navel Ill in Cow Calves. | |
| AR122160A1 (es) | PROCEDIMIENTO PARA EL TRATAMIENTO DE UNA INFECCIÓN VIRAL CON a-1-ANTITRIPSINA HUMANA | |
| ES2053585T3 (es) | Utilizacion de interferon-alfa bovino en la obtencion de un medicamento para el tratamiento profilactico de las vacas contra las enfermedades comprendidas bajo el termino generico de complejo de gripe bovina. | |
| Harris | Trigeminal neuralgia at exceptionally early age | |
| AR093734A1 (es) | Un metodo para tratar la enfermedad de lyme | |
| Khanzadeh et al. | Vaccines, adjuvants and conventional methods of using them in farmed fish | |
| Jaśkowski et al. | Sides effects of vaccination and Carofertin injections in cattle | |
| CN103006628A (zh) | 甲醛在制备治疗动物和人类传染病的注射剂中的应用 | |
| AR130444A1 (es) | Métodos para el tratamiento de infecciones virales | |
| MX2023012592A (es) | Composicion farmaceutica para el tratamiento de distemper no neurologico y neurologico en caninos, que comprende una formulacion a base de nanoparticulas de plata para uso por via oral y nasal. |